Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A
Duiyue Xu(China Pharmaceutical University), Changlin Zhou(China Pharmaceutical University)
Cited by 57
Related Papers
Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells
|International Journal of Oncology|2006|72